Sinopharm Holdings (01099) announced its results for the first quarter of 2024, with total revenue of about 147.266 billion yuan,...
According to the Zhitong Finance App, Sinopharm Holdings (01099) announced results for the first quarter of 2024. Total operating revenue was about 147.266 billion yuan, up 1.2% year on year; net profit attributable to owners of the parent company was about 1.42 billion yuan, a decrease of 10.7% year on year; basic earnings per share were 0.46 yuan.